The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical Journal

• Publication date

  1998-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ3310015PMID 9512456PMCID PMC1219315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.

  1997cited by this paper
• Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells.

  1997cited by this paper
• Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.

  1997cited by this paper
• Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes*

  1997cited by this paper
• A second endogenous cannabinoid that modulates long-term potentiation

  1997cited by this paper
• cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase

  1997cited by this paper
• Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells.

  1997cited by this paper
• Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells.

  1996cited by this paper
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

  1996cited by this paper
• The N-acylation-phosphodiesterase pathway and cell signalling.

  1996cited by this paper
• Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat

  1996cited by this paper
• Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.

  1995cited by this paper
• 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

  1995cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide (*)

  1995cited by this paper
• Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’

  1995cited by this paper
• Inhibitors of arachidonoyl ethanolamide hydrolysis.

  1994cited by this paper
• Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: sequential actions of diacylglycerol and monoacylglycerol lipases.

  1994cited by this paper
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons

  1994cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Monoglyceride and diglyceride lipases from human platelet microsomes.

  1988cited by this paper
• Purification and characterization of rat liver microsomal monoacylglycerol lipase in comparison to the other esterases.

  1977cited by this paper

• Cannabinoids in immune system-related diseases: From bench to clinic.

  2025cites this paper
• Deleting adipose FXR exacerbates metabolic defects and induces endocannabinoid lipid, 2-oleoyl glycerol, in obesity

  2025cites this paper
• Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications

  2022cites this paper
• Autism and associated disorders: cannabis as a potential therapy.

  2022cites this paper
• The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?

  2021cites this paper
• Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders

  2021cites this paper
• Molecular Mechanism and Cannabinoid Pharmacology.

  2020cites this paper
• Immunolocalization of cannabinoid receptor 1 (CB1), monoglyceride lipase (MGL) and fatty-acid amide hydrolase 1 (FAAH) in the pig claustrum.

  2020cites this paper
• An investigation into the targets for cannabinoid action in the ciliate Tetrahymena pyriformis

  2020cites this paper
• Effects of Dietary Bisphenol A on the Reproductive Function of Gilthead Sea Bream (Sparus aurata) Testes

  2019cites this paper
• A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.

  2019cites this paper
• The role of the endocannabinoid system in aetiopathogenesis of endometriosis: A potential therapeutic target.

  2019cites this paper
• Modulation of the Endocannabinoid System as a Potential Anticancer Strategy

  2019cites this paper
• Sterol Carrier Protein-2/Sterol Carrier Protein-x/Fatty Acid Binding Protein-1 Ablation Impacts Response of Brain Endocannabinoid to High-Fat Diet.

  2019cites this paper
• The role of the endocannabinoid system in preterm birth

  2018cites this paper
• Heterómeros de receptores CB1, CB2 y GPR55 y su implicación en enfermedades neurodegenerativas y alcoholismo

  2018cites this paper
• Targeting the endocannabinoid system as a potential anticancer approach

  2018cites this paper
• Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain: Studies in Animal Models

  2018cites this paper
• 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain.

  2018cites this paper
• Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.

  2018cites this paper
• Cannabinoids as Anticancer Drugs.

  2017cites this paper
• Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain

  2017influential citation
• Fabp1 gene ablation inhibits high‐fat diet‐induced increase in brain endocannabinoids

  2017cites this paper
• Investigation of Endocannabinoid System Signalling Pathways and Their Regulations in Endometrial Carcinoma

  2017cites this paper
• Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet[S]

  2017cites this paper
• Nutritional factors influencing tissue omega-3 metabolism and endocannabinoids levels in experimental models and humans

  2016cites this paper
• Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels

  2016cites this paper
• Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum.

  2016cites this paper
• Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system.

  2016influential citation
• Simultaneous HPLC-APCI-MS/MS quantification of endogenous cannabinoids and glucocorticoids in hair.

  2016cites this paper
• FABP‐1 gene ablation impacts brain endocannabinoid system in male mice

  2016cites this paper
• Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders.

  2016cites this paper
• Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection

  2015cites this paper
• Endocannabinoid transport revisited.

  2015cites this paper
• Endocannabinoid Regulation of Nausea and Emesis: The Role of 2-arachidonoylglycerol in LiCl-induced Vomiting in Suncus Murinus and Conditioned Gaping in Rats

  2015cites this paper
• Endocannabinoids — at the crossroads between the gut microbiota and host metabolism

  2015cites this paper
• Interaction Between the Endocannabinoid and Serotonergic System in the Exhibition of Head Twitch Response in Four Mouse Strains

  2014cites this paper
• Analysis of the structure and function of endocannabinoid-hydrolyzing enzymes using biophysical and nanomedical techniques

  2014cites this paper
• Endocannabinoid modulation of TLR4-induced neuroinflammation: implications for autism spectrum disorders

  2014cites this paper
• No more pain upon Gq‐protein‐coupled receptor activation: role of endocannabinoids

  2014cites this paper
• Endocannabinoid biochemistry: What do we know after 50 years?

  2014cites this paper
• The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184.

  2014cites this paper
• Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca2+-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus

  2014cites this paper
• Endocannabinoid signaling and its regulation by nutrients

  2014cites this paper
• The monoacylglycerol lipase inhibitor JZL184 attenuates LPS‐induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action

  2013cites this paper
• Nutritional Properties of Dietary Omega-3-Enriched Phospholipids

  2013cites this paper
• The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers

  2013cites this paper
• lterations in the endocannabinoid system in the rat valproic acid odel of autism

  2013cites this paper
• Insulin signalling depends on the endocannabinoid system in the brain

  2013cites this paper
• Targeting the cannabinoid system for pain relief?

  2013cites this paper
• Functional Autoradiography as a Pharmacological Approach for Studying G Protein-Coupled Lipid Receptor Signalling

  2013cites this paper
• Alterations in the endocannabinoid system in the rat valproic acid model of autism.

  2013cites this paper
• Arachidonate Remodeling and Inflammation

  2012cites this paper
• The role of the cannabinoid system in sepsis

  2012cites this paper
• Evidence for Bidirectional Endocannabinoid Transport across Cell Membranes*

  2012cites this paper
• Stable isotope liquid chromatography-tandem mass spectrometry assay for fatty acid amide hydrolase activity.

  2012cites this paper
• Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor.

  2012cites this paper
• Optimization and Development of In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2

  2012cites this paper
• The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.

  2011cites this paper
• Activation by 2‐arachidonoylglycerol of platelet p38MAPK/cPLA2 pathway

  2011cites this paper
• COX‐2 and fatty acid amide hydrolase can regulate the time course of depolarization‐induced suppression of excitation

  2011cites this paper
• Analysis of the role of cannabinoid receptors and 2-adrenoceptor subtypes in gastrointestinal functions

  2011cites this paper
• The Endocannabinoid 2-Arachidonoyl-Glycerol Activates Human Neutrophils: Critical Role of Its Hydrolysis and De Novo Leukotriene B4 Biosynthesis

  2011cites this paper
• This information is current as Biosynthesis 4 and De Novo Leukotriene B Neutrophils : Critical Role of Its Hydrolysis 2-Arachidonoyl-Glycerol Activates Human The Endocannabinoid

  2011cites this paper
• The MAGL Inhibitor, JZL184, Attenuates LiCl-Induced Vomiting in the Suncus murinus and 2AG Attenuates LiCl-Induced Nausea-Like Behavior in Rats

  2011cites this paper
• A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG).

  2011cites this paper
• Cannabinoids and sepsis

  2011cites this paper
• Changes in endocannabinoid signaling contribute to the anti-hyperalgesic effect of URB597 in a murine model of persistent inflammation.

  2011cites this paper
• Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies

  2010cites this paper
• Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide).

  2010cites this paper
• Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.

  2010cites this paper
• Endocannabinoids and pregnancy.

  2010cites this paper
• Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood.

  2010cites this paper
• THEMED ISSUE: CANNABINOIDS REVIEW The endocannabinoid system as a target for the treatment of neurodegenerative disease

  2010cites this paper
• Opioids and cannabinoids interactions: involvement in pain management.

  2010cites this paper
• The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: a role in uterine remodelling.

  2010cites this paper
• Cannabinoids and experimental models of multiple sclerosis.

  2010cites this paper
• An introduction to the endocannabinoid system: from the early to the latest concepts.

  2009cites this paper
• Candidate genes for cannabis use disorders: findings, challenges and directions.

  2009cites this paper
• Revised models of endocannabinoid signaling at inhibitory synapses in the brain

  2009cites this paper
• Metabolism of 2-acylglycerol in rabbit and human platelets. Involvement of monoacylglycerol lipase and fatty acid amide hydrolase

  2009cites this paper
• The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism.

  2009cites this paper
• Minireview: Endocannabinoids and their receptors as targets for obesity therapy.

  2009cites this paper
• The cellular processing of the endocannabinoid anandamide and its pharmacological manipulation

  2009cites this paper
• Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids.

  2009cites this paper
• The life cycle of the endocannabinoids: formation and inactivation.

  2009cites this paper
• Preclinical Pharmacological and Brain Bioassay Systems for CB1 Cannabinoid Receptors

  2009cites this paper
• Cannabinoid Receptors: A brief history and what not

  2009cites this paper
• The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons

  2008cites this paper
• Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2‐arachidonylglycerol

  2008cites this paper
• Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine.

  2008cites this paper
• The endocannabinoid 2‐arachidonoylglycerol activates human platelets through non‐CB1/CB2 receptors

  2008cites this paper
• Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.

  2008cites this paper
• 2-Arachidonoylglycerol (2-AG) membrane transport: History and outlook

  2008cites this paper
• FAAH and anandamide: is 2-AG really the odd one out?

  2008cites this paper
• The EC System in the Immune System and the Inflammatory Response

  2008cites this paper
• Endocannabinoid Modulation of Spatial Memory in Aversively and Appetitively Motivated Barnes Maze Tasks

  2008cites this paper
• Endocannabinoids: synthesis and degradation.

  2008cites this paper
• Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

  2008cites this paper
• Expression and function of fatty acid amide hydrolase in prostate cancer

  2008cites this paper